Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tarias
    Member
    • Sep 2011
    • 10

    #1

    De novo genome assembly question: which assembly should I use?

    I have sequenced two individuals and done three libraries per individual each with a different insert size (170, 500, 800).Using flow citometry I know this genome is 332MB. Also I know is diploid and the genetic variation is not to high. I have done different assemblies for a this plant genome and found this two were the best:

    One Individual
    3 libraries
    Insert size 170, 500, 800
    Number of clean reads 70,287,710
    Number of contigs 134,557
    Mean N50 length (bp) 5,050
    BUSCO 78.54


    Two Individuals
    2 individuals
    6 libraries
    Insert size 170, 500, 800
    Number of clean reads 209,022,970
    Number of contigs 446,608
    Mean N50 length (bp) 4,010.65
    BUSCO 76.38

    I then ran PEP_SCAFFOLDER in this two alignments and got this

    One Individual
    3 libraries


    Main genome scaffold total: 136339
    Main genome scaffold sequence total: 189.946 MB
    Main genome contig N/L50: 17091/2.413 KB

    Two Individuals
    2 individuals
    6 libraries


    Main genome scaffold total: 444336
    Main genome scaffold sequence total: 332.652 MB
    Main genome contig N/L50: 83374/706

    I have two questions:
    1. Would you annotate any of these two genomes?
    2. Which one would you annotate and why?

    Thanks,
    Tatiana
  • ctseto
    Member
    • Oct 2013
    • 44

    #2
    Annotation may reveal what's not there, esp if you know from exp that a given gene is present (eg someone PCR/subcloned ). Guessing eukaryote and that you may have hit some contigs that are repeat heavy (eg contig is pure repeat), and perhaps that your library isn't traversing those repeats?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...